ATE343590T1 - Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o - Google Patents

Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o

Info

Publication number: ATE343590T1
Authority: AT; Austria
Prior art keywords: radical; seq; peptide sequence; formula; val
Prior art date: 1997-04-09

Application number

AT98920571T

Other languages

English (en)

Inventor

Denis Marie Bernard Chenebaux

Jean-Francois Hubert Delagneau

Stephane Jean Xavier Gadelle

Francois Yves Rieunier

Original Assignee

Bio Rad Pasteur

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-09

Filing date

1998-04-06

Publication date

2006-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26233456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE343590(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-04-09 Priority claimed from FR9704356A external-priority patent/FR2761993B1/fr

1998-02-24 Priority claimed from FR9802212A external-priority patent/FR2775287B1/fr

1998-04-06 Application filed by Bio Rad Pasteur filed Critical Bio Rad Pasteur

2006-11-15 Application granted granted Critical

2006-11-15 Publication of ATE343590T1 publication Critical patent/ATE343590T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
241000713772 Human immunodeficiency virus 1 Species 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
238000012360 testing method Methods 0.000 title 1
150000001413 amino acids Chemical class 0.000 abstract 6
125000004432 carbon atom Chemical group C* 0.000 abstract 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
239000004472 Lysine Substances 0.000 abstract 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
125000003277 amino group Chemical group 0.000 abstract 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
-1 is OH Chemical compound 0.000 abstract 1
239000000178 monomer Substances 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
150000003573 thiols Chemical class 0.000 abstract 1
125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 abstract 1
239000004474 valine Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Communicable Diseases (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
AIDS & HIV (AREA)
Hematology (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT98920571T 1997-04-09 1998-04-06 Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o ATE343590T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9704356A FR2761993B1 (fr)	1997-04-09	1997-04-09	Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 groupe 0
FR9802212A FR2775287B1 (fr)	1998-02-24	1998-02-24	Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o

Publications (1)

Publication Number	Publication Date
ATE343590T1 true ATE343590T1 (de)	2006-11-15

Family

ID=26233456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98920571T ATE343590T1 (de)	1997-04-09	1998-04-06	Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o

Country Status (20)

Country	Link
US (2)	US7053175B1 (de)
EP (1)	EP0973802B1 (de)
JP (1)	JP3560987B2 (de)
KR (1)	KR100451312B1 (de)
CN (1)	CN1215082C (de)
AT (1)	ATE343590T1 (de)
AU (1)	AU740231B2 (de)
BR (1)	BRPI9809078B8 (de)
CA (1)	CA2286344C (de)
CZ (1)	CZ300927B6 (de)
DE (1)	DE69836265T2 (de)
ES (1)	ES2275305T3 (de)
IL (2)	IL132166A0 (de)
NO (1)	NO329149B1 (de)
NZ (1)	NZ500015A (de)
PL (1)	PL194863B1 (de)
PT (1)	PT973802E (de)
RU (1)	RU2184742C2 (de)
TR (1)	TR199902757T2 (de)
WO (1)	WO1998045323A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ300927B6 (cs) *	1997-04-09	2009-09-16	Bio-Rad Pasteur	Syntetický peptid monomerního typu, prostredek, který ho obsahuje, zpusob imunologické in vitro kvantifikace a diagnostický kit pro použití v biologických testech pro identifikaci infekcí zpusobených viry HIV
CA2290217C (en) *	1998-11-30	2010-01-12	Ortho-Clinical Diagnostics, Inc.	Peptides for the detection of hiv-1 group o
FR2874017B1 (fr) *	2004-08-06	2006-11-24	Bio Rad Pasteur Sa	Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih
EP2864787B1 (de)	2012-06-22	2017-11-01	Bio-Rad Laboratories, Inc.	Humaner faktor xiii als normalisierungskontrolle für immunoassays
CN112481246B (zh) *	2020-12-16	2022-03-29	熊猫乳品集团股份有限公司	一种生物活性多肽fspankkltpkky及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5204259A (en)	1988-05-06	1993-04-20	Pharmacia Genetic Engineering, Inc.	Methods and systems for producing HIV antigens
ATE174382T1 (de)	1992-10-06	1998-12-15	Dade Behring Marburg Gmbh	Retrovirus aus der hiv-gruppe und dessen verwendung
DE4405810A1 (de) *	1994-02-23	1995-08-24	Behringwerke Ag	Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
GB9410044D0 (en)	1994-05-19	1994-07-06	Int Murex Tech Corp	Assay
DE4430972A1 (de)	1994-07-25	1996-02-01	Boehringer Mannheim Gmbh	Bestimmung von spezifischem Immunglobulin unter Verwendung multipler Antigene
ATE374253T1 (de) *	1994-10-20	2007-10-15	Pasteur Institut	Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
DE19505262C2 (de)	1995-02-16	1998-06-18	Behring Diagnostics Gmbh	Retrovirus aus der HIV-Gruppe und dessen Verwendung
FR2731013B1 (fr) *	1995-02-27	1997-05-16	Inst Nat Sante Rech Med	Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
WO1996027012A1 (en)	1995-03-02	1996-09-06	Akzo Nobel N.V.	Specific hiv-1 group o antigens
US5569553A (en)	1995-03-08	1996-10-29	Wilson Greatbatch Ltd.	Battery design for achieving end-of-life indication during electrical discharge
DE19622088A1 (de)	1996-05-31	1997-12-04	Boehringer Mannheim Gmbh	Anti-HIV-Antikörper als Kontrollproben
CZ300927B6 (cs) *	1997-04-09	2009-09-16	Bio-Rad Pasteur	Syntetický peptid monomerního typu, prostredek, který ho obsahuje, zpusob imunologické in vitro kvantifikace a diagnostický kit pro použití v biologických testech pro identifikaci infekcí zpusobených viry HIV
EP1003878A2 (de)	1997-07-18	2000-05-31	Innogenetics N.V.	Antigene von hiv-1 gruppe o und deren verwendungen

1998
- 1998-04-06 CZ CZ0357599A patent/CZ300927B6/cs unknown
- 1998-04-06 AU AU73386/98A patent/AU740231B2/en not_active Expired
- 1998-04-06 EP EP98920571A patent/EP0973802B1/de not_active Expired - Lifetime
- 1998-04-06 CA CA2286344A patent/CA2286344C/fr not_active Expired - Lifetime
- 1998-04-06 PT PT98920571T patent/PT973802E/pt unknown
- 1998-04-06 CN CNB988052024A patent/CN1215082C/zh not_active Expired - Lifetime
- 1998-04-06 PL PL336115A patent/PL194863B1/pl unknown
- 1998-04-06 DE DE69836265T patent/DE69836265T2/de not_active Expired - Lifetime
- 1998-04-06 WO PCT/FR1998/000691 patent/WO1998045323A1/fr not_active Ceased
- 1998-04-06 ES ES98920571T patent/ES2275305T3/es not_active Expired - Lifetime
- 1998-04-06 AT AT98920571T patent/ATE343590T1/de not_active IP Right Cessation
- 1998-04-06 IL IL13216698A patent/IL132166A0/xx active IP Right Grant
- 1998-04-06 JP JP54245598A patent/JP3560987B2/ja not_active Expired - Lifetime
- 1998-04-06 BR BRPI9809078A patent/BRPI9809078B8/pt not_active IP Right Cessation
- 1998-04-06 RU RU99123443/04A patent/RU2184742C2/ru active
- 1998-04-06 TR TR1999/02757T patent/TR199902757T2/xx unknown
- 1998-04-06 NZ NZ500015A patent/NZ500015A/en not_active IP Right Cessation
- 1998-04-06 US US09/147,362 patent/US7053175B1/en not_active Expired - Lifetime
- 1998-04-06 KR KR10-1999-7009296A patent/KR100451312B1/ko not_active Expired - Lifetime
1999
- 1999-09-30 IL IL132166A patent/IL132166A/en not_active IP Right Cessation
- 1999-10-08 NO NO19994929A patent/NO329149B1/no not_active IP Right Cessation
2006
- 2006-04-13 US US11/402,876 patent/US7838001B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7053175B1 (en)	2006-05-30
PL194863B1 (pl)	2007-07-31
EP0973802B1 (de)	2006-10-25
CN1256695A (zh)	2000-06-14
JP2001519800A (ja)	2001-10-23
IL132166A (en)	2006-12-10
CN1215082C (zh)	2005-08-17
KR100451312B1 (ko)	2004-10-06
US20060234213A1 (en)	2006-10-19
DE69836265T2 (de)	2007-05-31
RU2184742C2 (ru)	2002-07-10
JP3560987B2 (ja)	2004-09-02
BRPI9809078B8 (pt)	2021-05-25
WO1998045323A1 (fr)	1998-10-15
TR199902757T2 (xx)	2000-02-21
KR20010006216A (ko)	2001-01-26
US7838001B2 (en)	2010-11-23
IL132166A0 (en)	2001-03-19
CZ300927B6 (cs)	2009-09-16
CA2286344C (fr)	2012-08-07
ES2275305T3 (es)	2007-06-01
BR9809078A (pt)	2000-08-01
PT973802E (pt)	2007-01-31
CA2286344A1 (fr)	1998-10-15
AU7338698A (en)	1998-10-30
DE69836265D1 (de)	2006-12-07
AU740231B2 (en)	2001-11-01
NZ500015A (en)	2001-06-29
NO994929D0 (no)	1999-10-08
CZ357599A3 (cs)	2000-06-14
NO329149B1 (no)	2010-08-30
EP0973802A1 (de)	2000-01-26
PL336115A1 (en)	2000-06-05
BR9809078B1 (pt)	2012-12-11
NO994929L (no)	1999-12-08

Legal Events

Date	Code	Title	Description
2007-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
Denkewalter et al.	1969	Total synthesis of an enzyme. I. Objective and strategy
Karplus et al.	1984	Amino acid sequence of spinach ferredoxin: NADP oxidoreductase
Butler	1970	Chemical studies on the cyanogen bromide peptides of rat skin collagen. Covalent structure of α1-CB5, the major hexose-containing cyanogen bromide peptide of α1
CA1246054A (en)	1988-12-06	Synthetic st toxin, process for its preparation and its use as a vaccinating agent
DE68913935D1 (de)	1994-04-21	Verfahren zur Herstellung von Retro-Inverso-Peptiden und dessen Zwischenprodukte.
Atherton et al.	1985	Peptide synthesis. Part 7. Solid-phase synthesis of conotoxin G1
Jupp et al.	1988	Identification of the aspartic proteinases from human erythrocyte membranes and gastric mucosa (slow-moving proteinase) as catalytically equivalent to cathepsin E
MX2023005770A (es)	2023-08-01	Tetrapeptido y composiciones que comprenden tetrapeptidos.
Nolan et al.	1966	Primary structure of the cytochrome c from the great grey kangaroo, Macropus canguru
ATE343590T1 (de)	2006-11-15	Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o
König et al.	1979	The amino acid sequence of the peptide moiety of the pseudomurein from Methanobacterium thermoautotrophicum
GB1594039A (en)	1981-07-30	F-endorphin polypeptide analogues and a process for the manufacture thereof
GB1521919A (en)	1978-08-16	Process for the manufacture of human insulin
DE69233245D1 (de)	2003-12-11	Verfahren zur Herstellung von Peptiden
ATE290088T1 (de)	2005-03-15	Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
ZA200109110B (en)	2002-06-13	Long lasting fusion peptide inhibitors or viral infection.
Buck et al.	1992	Comparative investigations on the amino-acid sequences of different isolectins from the sponge Axinella polypoides (Schmidt)
Bruton	1975	The infrastructure of valyl-transfer Ribonucleic Acid synthetase from yeast
IL142709A0 (en)	2002-03-10	Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
ATE135407T1 (de)	1996-03-15	Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
AU623687B2 (en)	1992-05-21	New pentapeptide and a process for the preparation thereof
Gish	1961	Studies on the Amino Acid Sequence of Tobacco Mosaic Virus (TMV) Protein. IV. The Amino Acid Sequences of an Eicosapeptide and a Heptadecapeptide Isolated from a Tryptic Digest of TMV Protein1
ATE85077T1 (de)	1993-02-15	Enzym zur alpha-amidierung von c-termini und verfahren zu dessen herstellung.
Morley et al.	1981	MPF analogue with high stability to proteolysis
ATE348840T1 (de)	2007-01-15	Verfahren zur prävention einer durch gefrieren induzierten abnahme der aktivität eines proteins